Axel Svenningsson

Axel Svenningsson is a Researcher at Lund University's Faculty of Medicine, actively participating in the Translational Infection Medicine research project. His work focuses on cellular mechanisms at the intersection of infection biology and oncology, with institutional affiliation confirmed through recent scholarly output and university email correspondence.

His research spans Cell Biology, Molecular Biology, and Cancer Research, with specialized expertise in membrane dynamics during cell death. Key investigations include endoplasmic reticulum remodeling, nuclear shape alterations, and peptide-lipid complex interactions in tumor environments, utilizing biochemical and molecular approaches to dissect cellular responses in disease contexts.

His 2025 publication on ER remodeling in dying tumor cells demonstrates active contribution to oncology research, evidenced by citation metrics (1 citation), reader engagement (5 Mendeley readers), and media attention (2 news outlets, 16 social shares). This work reveals novel mechanisms of cancer cell death through lipid-mediated membrane restructuring.

• Scientific Recognition: No formal awards documented in available sources

No information regarding student supervision, grant leadership, or laboratory direction was identified in current records. Research activities appear integrated within collaborative project frameworks at Lund University.

Dr. Svenningsson contributes to translational research teams investigating infection-cancer interfaces, with current work emphasizing membrane biology applications in therapeutic development for tumor microenvironments.